Emergent BioSolutions to Participate in Virtual Investor Conferences
August 18 2020 - 6:31AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that members
of the company’s executive management team will participate in the
following virtual investor conferences through the end of September
2020:
- 2020 NYSE Healthcare & Technology Investor Access
Day August 18 – virtual one-on-one meetings
only
- 2020 Three Part Advisors Virtual Midwest IDEAS Investor
Conference August 27 – pre-recorded presentation available
beginning at 8:00am eastern
- 2020 Wells Fargo Virtual Healthcare
ConferenceSeptember 9 – presentation at 8:00am
eastern
- Robert W. Baird 2020 Global Healthcare
ConferenceSeptember 10 – presentation at 2:35pm
eastern
- Morgan Stanley 18th Annual Global Healthcare Conference
2020September 14 – presentation at 4:30pm eastern
- Cantor Virtual Global Healthcare Conference
2020September 15 – presentation at 3:20pm eastern
- 2020 Singular Research Compelling Values
WebcallSeptember 17 – presentation at 12:00pm eastern
For conferences where a presentation is planned, the company’s
webcast presentation may include a discussion of the company’s
recent business developments as well as its financial results and
guidance. The webcasts will be available both live, if possible,
and by replay, and will be accessible from the Emergent website
www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutionsEmergent
BioSolutions is a global life sciences company whose mission is to
protect and enhance life. Through our specialty products and
contract development and manufacturing services, we are dedicated
to providing solutions that address public health threats. Through
social responsibility, we aim to build healthier and safer
communities. We aspire to deliver peace of mind to our patients and
customers so they can focus on what’s most important in their
lives. In working together, we envision protecting or enhancing 1
billion lives by 2030. For more information visit
www.emergentbiosolutions.com. Find us on LinkedIn and follow us on
Twitter @emergentbiosolu and Instagram @life_at_emergent.
Investor Contact:Robert G. BurrowsVice
President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Miko B. NeriSenior Director,
Global Communications & Public
Affairs240-631-3392nerim@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024